| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8944395 | Journal of Cardiac Failure | 2018 | 21 Pages |
Abstract
PAPi serves as a marker of RV dysfunction and strongly predicts adverse clinical events in patients with advanced heart failure. Incorporating PAPi into existing risk models can substantially improve patient selection for advanced therapies and clinical outcomes in this population.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Stephanie Meller MD, Raul J. MD, Lauren K. MD, Veli K. MD,